scout
|Videos|February 1, 2017

Cobimetinib Plus Paclitaxel in TNBC

Adam M. Brufsky, MD, PhD, discusses combining cobimetinib and paclitaxel as a first-line treatment in patients with advanced triple-negative breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME